Thirumalai Chemicals Ltd
- Market Cap ₹ 3,771 Cr.
- Current Price ₹ 368
- High / Low ₹ 395 / 196
- Stock P/E
- Book Value ₹ 118
- Dividend Yield 0.27 %
- ROCE 0.35 %
- ROE -3.32 %
- Face Value ₹ 1.00
Pros
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 10.2% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.21.0 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of Nifty Microcap 250 BSE SmallCap BSE Commodities Nifty Total Market BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,369 | 1,275 | 1,070 | 940 | 1,028 | 1,312 | 1,261 | 1,085 | 1,086 | 1,998 | 2,132 | 2,083 | 2,098 | |
1,234 | 1,192 | 1,032 | 842 | 871 | 1,022 | 1,055 | 1,007 | 865 | 1,557 | 1,946 | 2,032 | 2,046 | |
Operating Profit | 135 | 83 | 38 | 98 | 158 | 290 | 206 | 78 | 221 | 441 | 186 | 51 | 52 |
OPM % | 10% | 7% | 4% | 10% | 15% | 22% | 16% | 7% | 20% | 22% | 9% | 2% | 2% |
5 | 3 | 8 | 5 | 4 | 7 | 12 | 21 | 7 | 12 | 30 | 19 | 21 | |
Interest | 52 | 49 | 35 | 23 | 17 | 13 | 12 | 17 | 21 | 20 | 31 | 42 | 41 |
Depreciation | 23 | 23 | 18 | 25 | 36 | 31 | 36 | 44 | 50 | 57 | 56 | 63 | 59 |
Profit before tax | 64 | 15 | -7 | 55 | 109 | 253 | 169 | 38 | 157 | 375 | 129 | -35 | -27 |
Tax % | 32% | 20% | 102% | 41% | 35% | 33% | 33% | 39% | 25% | 25% | 31% | 12% | |
44 | 12 | -14 | 32 | 71 | 170 | 114 | 23 | 118 | 281 | 90 | -39 | -33 | |
EPS in Rs | 4.28 | 1.16 | -1.34 | 3.14 | 6.90 | 16.64 | 11.09 | 2.26 | 11.49 | 27.47 | 8.77 | -3.79 | -3.26 |
Dividend Payout % | 18% | 0% | -30% | 51% | 27% | 12% | 18% | 0% | 19% | 9% | 17% | -26% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 11% |
3 Years: | 24% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -30518% |
Stock Price CAGR | |
---|---|
10 Years: | 44% |
5 Years: | 43% |
3 Years: | 17% |
1 Year: | 71% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 10% |
3 Years: | 10% |
Last Year: | -3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 189 | 205 | 183 | 208 | 388 | 563 | 658 | 628 | 793 | 1,075 | 1,182 | 1,136 | 1,199 |
305 | 222 | 142 | 91 | 62 | 50 | 103 | 197 | 183 | 165 | 514 | 1,252 | 1,384 | |
289 | 321 | 212 | 211 | 327 | 202 | 370 | 365 | 358 | 612 | 654 | 922 | 875 | |
Total Liabilities | 793 | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,469 |
249 | 230 | 243 | 256 | 317 | 310 | 383 | 550 | 513 | 596 | 671 | 712 | 856 | |
CWIP | 1 | 18 | 7 | 18 | 9 | 44 | 159 | 82 | 126 | 64 | 406 | 1,200 | 1,310 |
Investments | 5 | 5 | 5 | 5 | 77 | 104 | 150 | 49 | 136 | 180 | 132 | 173 | 218 |
538 | 503 | 291 | 241 | 383 | 367 | 449 | 519 | 569 | 1,022 | 1,150 | 1,236 | 1,084 | |
Total Assets | 793 | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,469 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
19 | 133 | 154 | 126 | 108 | 81 | 234 | 140 | 221 | 402 | 54 | 237 | |
-0 | -15 | -19 | -32 | -44 | -54 | -221 | -36 | -159 | -134 | -335 | -824 | |
-26 | -116 | -142 | -93 | -52 | -16 | 16 | 46 | -38 | -70 | 206 | 643 | |
Net Cash Flow | -7 | 3 | -8 | 0 | 12 | 10 | 29 | 150 | 24 | 198 | -75 | 56 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 75 | 66 | 52 | 50 | 49 | 33 | 33 | 30 | 29 | 29 | 17 | 32 |
Inventory Days | 67 | 74 | 42 | 38 | 82 | 59 | 84 | 69 | 74 | 74 | 76 | 55 |
Days Payable | 83 | 59 | 38 | 92 | 139 | 53 | 119 | 123 | 129 | 141 | 118 | 113 |
Cash Conversion Cycle | 60 | 82 | 56 | -3 | -8 | 39 | -2 | -24 | -26 | -39 | -25 | -26 |
Working Capital Days | 53 | 42 | 19 | 1 | 2 | 37 | 4 | -5 | -11 | -18 | -10 | -30 |
ROCE % | 25% | 14% | 7% | 24% | 33% | 49% | 26% | 7% | 20% | 35% | 11% | 0% |
Documents
Announcements
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
9 Dec - Issue of duplicate share certificates for shareholders.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 7 Dec
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 3 Dec
-
Reg. 30 Of The SEBI (LODR) Regulations, 2015,
26 Nov - Received notice from tax authority regarding alleged violations.
-
Material Event
22 Nov - Equity infusion of USD 45 Mn and INR 200 Cr loan.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Products